These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34585697)

  • 1. mRNA-based CAR T-cells manufactured by miniaturized two-step electroporation produce selective cytotoxicity toward target cancer cells.
    Jayasooriya V; Ringwelski B; Dorsam G; Nawarathna D
    Lab Chip; 2021 Sep; 21(19):3748-3761. PubMed ID: 34585697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.
    Zhao Y; Moon E; Carpenito C; Paulos CM; Liu X; Brennan AL; Chew A; Carroll RG; Scholler J; Levine BL; Albelda SM; June CH
    Cancer Res; 2010 Nov; 70(22):9053-61. PubMed ID: 20926399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
    Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
    BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma.
    Simon B; Harrer DC; Schuler-Thurner B; Schaft N; Schuler G; Dörrie J; Uslu U
    Exp Dermatol; 2018 Jul; 27(7):769-778. PubMed ID: 29704887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured
    Niu A; Zou J; Hu X; Zhang Z; Su L; Wang J; Lu X; Zhang W; Chen W; Zhang X
    Front Immunol; 2023; 14():1068625. PubMed ID: 37228617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development.
    Miliotou AN; Papadopoulou LC
    Methods Mol Biol; 2020; 2086():87-117. PubMed ID: 31707670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced leukemia in mice with mRNA engineered T cells.
    Barrett DM; Zhao Y; Liu X; Jiang S; Carpenito C; Kalos M; Carroll RG; June CH; Grupp SA
    Hum Gene Ther; 2011 Dec; 22(12):1575-86. PubMed ID: 21838572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomaterials in Chimeric Antigen Receptor T-Cell Process Development.
    Cardle II; Cheng EL; Jensen MC; Pun SH
    Acc Chem Res; 2020 Sep; 53(9):1724-1738. PubMed ID: 32786336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update.
    Soundara Rajan T; Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automating CAR-T Transfection with Micro and Nano-Technologies.
    Hu T; Kumar AR; Luo Y; Tay A
    Small Methods; 2024 Aug; 8(8):e2301300. PubMed ID: 38054597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
    Billingsley MM; Singh N; Ravikumar P; Zhang R; June CH; Mitchell MJ
    Nano Lett; 2020 Mar; 20(3):1578-1589. PubMed ID: 31951421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA.
    Osman Y; Narita M; Ayres F; Takahashi M; Alldawi L; Tatsuo F; Toba K; Hirohashi T; Aizawa Y
    Cytotherapy; 2003; 5(2):161-8. PubMed ID: 12745578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.
    Sauerer T; Albrecht L; Sievers NM; Gerer KF; Hoyer S; Dörrie J; Schaft N
    Methods Mol Biol; 2024; 2786():219-235. PubMed ID: 38814397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized DNA electroporation for primary human T cell engineering.
    Zhang Z; Qiu S; Zhang X; Chen W
    BMC Biotechnol; 2018 Jan; 18(1):4. PubMed ID: 29378552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency.
    Wang W; Ma Y; Li J; Shi HS; Wang LQ; Guo FC; Zhang J; Li D; Mo BH; Wen F; Liu T; Liu YT; Wang YS; Wei YQ
    Gene Ther; 2013 Oct; 20(10):970-8. PubMed ID: 23636245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large volume flow electroporation of mRNA: clinical scale process.
    Li L; Allen C; Shivakumar R; Peshwa MV
    Methods Mol Biol; 2013; 969():127-38. PubMed ID: 23296932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective modification of antigen-specific T cells by RNA electroporation.
    Mitchell DA; Karikari I; Cui X; Xie W; Schmittling R; Sampson JH
    Hum Gene Ther; 2008 May; 19(5):511-21. PubMed ID: 18471037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.
    Poirot L; Philip B; Schiffer-Mannioui C; Le Clerre D; Chion-Sotinel I; Derniame S; Potrel P; Bas C; Lemaire L; Galetto R; Lebuhotel C; Eyquem J; Cheung GW; Duclert A; Gouble A; Arnould S; Peggs K; Pule M; Scharenberg AM; Smith J
    Cancer Res; 2015 Sep; 75(18):3853-64. PubMed ID: 26183927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications.
    Kavanagh H; Dunne S; Martin DS; McFadden E; Gallagher L; Schwaber J; Leonard S; O'Dea S
    Cytotherapy; 2021 Sep; 23(9):852-860. PubMed ID: 33941482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma.
    Wang H; Wang X; Ye X; Ju Y; Cao N; Wang S; Cai J
    BMC Cancer; 2022 Jul; 22(1):814. PubMed ID: 35879685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.